Profile | GDS5420 / 228926_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1253.34 | 83 |
GSM1296119 | B_lesional_pre-dose | 967.34 | 79 |
GSM1296076 | C_lesional_pre-dose | 525.18 | 69 |
GSM1296092 | D_lesional_pre-dose | 528.56 | 69 |
GSM1296103 | E_lesional_pre-dose | 1436.57 | 85 |
GSM1296078 | F_lesional_pre-dose | 477.7 | 68 |
GSM1296107 | G_lesional_pre-dose | 984.62 | 79 |
GSM1296109 | H_lesional_pre-dose | 1143.32 | 82 |
GSM1296080 | I_lesional_pre-dose | 767.15 | 75 |
GSM1296090 | J_lesional_pre-dose | 576.91 | 70 |
GSM1296074 | K_lesional_pre-dose | 414.06 | 66 |
GSM1296111 | L_lesional_pre-dose | 899.41 | 78 |
GSM1296099 | M_lesional_pre-dose | 953.42 | 78 |
GSM1296086 | O_lesional_pre-dose | 588.24 | 71 |
GSM1296117 | P_lesional_pre-dose | 911 | 78 |
GSM1296113 | Q_lesional_pre-dose | 1003.03 | 80 |
GSM1296096 | R_lesional_pre-dose | 1025.15 | 79 |
GSM1296105 | S_lesional_pre-dose | 1299.85 | 83 |
GSM1296098 | T_lesional_pre-dose | 1650.07 | 87 |
GSM1296101 | U_lesional_pre-dose | 1473.7 | 85 |
GSM1296121 | V_lesional_pre-dose | 1087.66 | 81 |
GSM1296088 | W_lesional_pre-dose | 826.77 | 76 |
GSM1296082 | X_lesional_pre-dose | 542.35 | 70 |
GSM1296115 | Y_lesional_pre-dose | 847.92 | 77 |
GSM1296084 | Z_lesional_pre-dose | 868.11 | 77 |
GSM1296072 | B_lesional_day8 | 1083.6 | 81 |
GSM1296069 | L_lesional_day8 | 1124.3 | 82 |
GSM1296071 | P_lesional_day8 | 1181.83 | 82 |
GSM1296070 | Y_lesional_day8 | 901.15 | 78 |
GSM1296073 | V_lesional_day8 | 634.51 | 72 |
GSM1296034 | A_lesional_day15 | 1981.63 | 90 |
GSM1296041 | G_lesional_day15 | 720.94 | 74 |
GSM1296035 | R_lesional_day15 | 1029.94 | 79 |
GSM1296038 | U_lesional_day15 | 1195.12 | 82 |
GSM1296047 | B_lesional_day15 | 1185.72 | 82 |
GSM1296039 | E_lesional_day15 | 817.8 | 76 |
GSM1296042 | H_lesional_day15 | 898.76 | 78 |
GSM1296043 | L_lesional_day15 | 916.77 | 78 |
GSM1296037 | M_lesional_day15 | 1125.88 | 81 |
GSM1296046 | P_lesional_day15 | 1206.51 | 83 |
GSM1296044 | Q_lesional_day15 | 1226.95 | 83 |
GSM1296045 | Y_lesional_day15 | 1045.43 | 80 |
GSM1296025 | C_lesional_day15 | 962.07 | 78 |
GSM1296033 | D_lesional_day15 | 735.86 | 74 |
GSM1296027 | I_lesional_day15 | 565.15 | 70 |
GSM1296032 | J_lesional_day15 | 987.77 | 79 |
GSM1296024 | K_lesional_day15 | 867.4 | 77 |
GSM1296031 | W_lesional_day15 | 1201.42 | 82 |
GSM1296028 | X_lesional_day15 | 911.32 | 77 |
GSM1296029 | Z_lesional_day15 | 949.64 | 78 |
GSM1296026 | F_lesional_day15 | 577.2 | 70 |
GSM1296030 | O_lesional_day15 | 580.12 | 70 |
GSM1296040 | S_lesional_day15 | 1921.47 | 89 |
GSM1296036 | T_lesional_day15 | 1638.07 | 87 |
GSM1296048 | V_lesional_day15 | 815.36 | 76 |
GSM1296059 | A_lesional_day43 | 1445.7 | 84 |
GSM1296066 | G_lesional_day43 | 1068.37 | 81 |
GSM1296060 | R_lesional_day43 | 953.9 | 78 |
GSM1296063 | U_lesional_day43 | 920.55 | 78 |
GSM1296064 | E_lesional_day43 | 984.79 | 79 |
GSM1296067 | H_lesional_day43 | 1049.59 | 80 |
GSM1296062 | M_lesional_day43 | 1211.15 | 82 |
GSM1296068 | Q_lesional_day43 | 1199.54 | 83 |
GSM1296050 | C_lesional_day43 | 1023.09 | 79 |
GSM1296057 | D_lesional_day43 | 1318.6 | 83 |
GSM1296052 | I_lesional_day43 | 547.25 | 69 |
GSM1296054 | J_lesional_day43 | 1293.06 | 83 |
GSM1296049 | K_lesional_day43 | 1047.3 | 80 |
GSM1296055 | W_lesional_day43 | 1429.9 | 85 |
GSM1296053 | X_lesional_day43 | 1096.47 | 80 |
GSM1296058 | Z_lesional_day43 | 1400.67 | 84 |
GSM1296051 | F_lesional_day43 | 657.14 | 73 |
GSM1296056 | O_lesional_day43 | 830.43 | 76 |
GSM1296065 | S_lesional_day43 | 955.32 | 78 |
GSM1296061 | T_lesional_day43 | 1556.72 | 86 |
GSM1296095 | A_non-lesional_pre-dose | 1232.75 | 82 |
GSM1296120 | B_non-lesional_pre-dose | 1021.33 | 80 |
GSM1296077 | C_non-lesional_pre-dose | 828.13 | 76 |
GSM1296093 | D_non-lesional_pre-dose | 1514.63 | 86 |
GSM1296104 | E_non-lesional_pre-dose | 1365.3 | 84 |
GSM1296079 | F_non-lesional_pre-dose | 1037.2 | 80 |
GSM1296108 | G_non-lesional_pre-dose | 1304.54 | 83 |
GSM1296110 | H_non-lesional_pre-dose | 1369.36 | 85 |
GSM1296081 | I_non-lesional_pre-dose | 1339.21 | 83 |
GSM1296091 | J_non-lesional_pre-dose | 660.09 | 72 |
GSM1296075 | K_non-lesional_pre-dose | 700.17 | 74 |
GSM1296112 | L_non-lesional_pre-dose | 1018.34 | 80 |
GSM1296100 | M_non-lesional_pre-dose | 1690.07 | 87 |
GSM1296087 | O_non-lesional_pre-dose | 516.77 | 69 |
GSM1296118 | P_non-lesional_pre-dose | 1302.45 | 84 |
GSM1296114 | Q_non-lesional_pre-dose | 1268.12 | 83 |
GSM1296097 | R_non-lesional_pre-dose | 1215.12 | 82 |
GSM1296106 | S_non-lesional_pre-dose | 1456.85 | 85 |
GSM1296102 | U_non-lesional_pre-dose | 1516.17 | 86 |
GSM1296122 | V_non-lesional_pre-dose | 1256.19 | 83 |
GSM1296089 | W_non-lesional_pre-dose | 1054.1 | 80 |
GSM1296083 | X_non-lesional_pre-dose | 1796.9 | 88 |
GSM1296116 | Y_non-lesional_pre-dose | 994.9 | 79 |
GSM1296085 | Z_non-lesional_pre-dose | 861.84 | 76 |